Eclinicalworks India Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 02-01-2025
- Paid Up Capital ₹ 8.11 Cr
as on 02-01-2025
- Company Age 18 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 13.03%
(FY 2022)
- Profit 30.80%
(FY 2022)
- Ebitda 7.02%
(FY 2022)
- Net Worth 7.40%
(FY 2022)
- Total Assets 8.68%
(FY 2022)
About Eclinicalworks India
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 8.11 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Eclinicalworks India Private Limited India is Shimul Panchal as COMPANY SECRETARY. Mahesh Navani, Rajesh Dharampuriya, Girish Navani, and One other member serve as directors at the Company.
- CIN/LLPIN
U72200GJ2006PTC103894
- Company No.
103894
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Oct 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Eclinicalworks India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shimul Panchal | Company Secretary | 15-Nov-2024 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahesh Navani  | Director | 18-Dec-2006 | Current |
| Rajesh Dharampuriya | Director | 18-Dec-2006 | Current |
| Girish Navani | Director | 18-Dec-2006 | Current |
Aum Patel  | Director | 25-Jul-2018 | Current |
Financial Performance of Eclinicalworks India.
Eclinicalworks India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.03% increase. The company also saw a substantial improvement in profitability, with a 30.8% increase in profit. The company's net worth moved up by a moderate rise of 7.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eclinicalworks India?
In 2022, Eclinicalworks India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eclinical India Private LimitedActive 9 years 6 monthsMahesh Navani, Rajesh Dharampuriya and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eclinicalworks India?
Eclinicalworks India has a workforce of 4671 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eclinicalworks India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eclinicalworks India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
